Neda Safarzadeh | Head, IR |
Joseph Payne | President and CEO |
Andy Sassine | CFO |
Dr. Pad Chivukula | Chief Scientific Officer and COO |
Ed Arce | H.C. Wainwright |
Kumar Raja | Brookline Capital |
Wangzhi Li | Ladenburg Thalmann |
Greetings and welcome to the Arcturus Therapeutics Holdings Second Quarter 2019 Earnings Results Conference Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.
I would now like to turn the conference over to your host, Neda Safarzadeh, Head of Investor Relations.